Form 4: RxSight Director Reports Stock Transactions
Insider Transaction Report
RxSight, Inc. Director Jesse Anderson Corley filed a Form 4 reporting the acquisition of 37,037 shares of common stock.
Summary
- Jesse Anderson Corley, a Director at RxSight, Inc., reported a transaction on June 17, 2026.
- The transaction involved the acquisition of 37,037 shares of common stock.
- Following this transaction, Corley beneficially owns 86,227 shares directly.
- Additional holdings include 3,210 shares held by spouse, 474,141 shares held by the Andy Corley Living Trust, 7,083 shares held by The Corley Foundation, and 18,708 shares held by the Juana McKay Living Trust.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it primarily reports on routine insider stock transactions and a power of attorney, without providing new financial or strategic information.
Positives
- Director Jesse Anderson Corley acquired additional shares, indicating continued investment or compensation.
- The acquisition of 37,037 shares suggests a positive view or commitment to the company.
Future Outlook
The filing does not contain forward-looking statements or guidance.
Industry Context
StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions, providing transparency into the holdings and activities of company directors and officers. This specific filing indicates a director's acquisition of shares, which can be interpreted in various ways depending on the context of the award and the individual's overall holdings.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney | Jesse Anderson Corley granted a power of attorney to specific individuals to execute and submit SEC filings on his behalf, including Forms 3, 4, 5, Schedules 13D and 13G, and Forms 144. This also authorizes the attorneys-in-fact to obtain information regarding company securities transactions. | 02/24/2026 | Facilitates efficient and timely compliance with reporting obligations for insider transactions and ownership. |
Stakeholder Impact
- Shareholders: Increased transparency regarding director's stock holdings and transactions.
Key Dates
| Date | Description |
|---|---|
| 06/17/2026 | Date of earliest transaction reported and Date of Grant for RSUs. |
| 02/24/2026 | Date of execution for the Power of Attorney. |
| 06/18/2026 | Date of signature for the Form 4 filing. |
Keywords
RxSight, Inc., Form 4, Director, Stock Transaction, Beneficial Ownership, Common Stock, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.